medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2003, Número 4

<< Anterior Siguiente >>

Ann Hepatol 2003; 2 (4)


Liver fibrosis and inflammation. A review

Kershenobich SD, Bonder WA

Idioma: Ingles.
Referencias bibliográficas: 41
Paginas: 159-163
Archivo PDF: 67.40 Kb.


FRAGMENTO

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Gutierrez-Ruiz C, Robles-Diaz G, Kershenobich D. Emerging concepts in inflammation and fibrosis. Archives of medical research. 2002; 33: 595–599.

  2. Schuppan D, Ruehl M, Somasundaram R, Hahn EG. Matrix as modulator of stellate cell and hepatic fibrogenesis. Semin Liver Dis 2001: 351–372.

  3. Benyon D, Arthur MJP. Extracellular matrix degradation and the role of stellate cells. Semin Liver Dis 2001; 21: 373-384.

  4. Goodman ZD. Pathologic evaluation of fibrosis in Liver Disease in the 21st Century. Postgraduate course sylabus. AGA 2003.

  5. Marra F. Hepatic stellate cells and the regulation of liver inflammation. J Hepatol 1999; 31: 1120–1130.

  6. Granger DN, Kubes P. The microcirculation and inflammation modulation of leukocytre- endothelial cell adhesion. J Leukocyte Biol 1994; 55: 662–675.

  7. Smith CN. Transendothelial migration in Harlan J.M. Liviy Eds. Adhesion: its role in inflammatory disease. New York: W.H. and Co. 1992: 82–115.

  8. Crockett-Torabi E. Selectins and mechanisms of signal transduction. J Leukocyte Biol 1990; 63: 1-14.

  9. Canbay A, Feldstein A, Higuchi H, Werneburg N, Grambihler A, Bronk S, Gores G. Kupffer Cell Engulfment of Apoptotic Bodies Stimulates Death Ligand and Cytokine Expression. Hepatology 2003; 35: 1188-1198.

  10. Kojima Y, Suzuki S, Tsuchiya Y, Konno H, Baba S, Nakamura S. Regulation of pro- inflammatory and anti- inflammatory cytokine responses by kupffer cells in endotoxin- enhaced reperfusion injury after total hepatic ischemia. Transpl Int 2003; 16: 231-240.

  11. Sun Z, Wada T, Maemura K, Uchikura K, Hoshino S, Diehl AM, Klein AS. Hepatic allograft–derived Kupffer cells regulate T cell response in rats. Liver Transpl 2003; 9: 489–497.

  12. Fischer R, Caries A, Reinehr R, Haussinger D. Caspase 9-dependent killing of hepatic stellate cells by activated Kupffer cells. Gastroenterology 2002; 123: 845–861.

  13. Adachi Y, Bradford BU, Gao W, Bojes HK, Thurman RG. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology 1994; 20: 453-460.

  14. Jaechke H. Inflammation in response to hepatocellular apoptosis. Hepatology 2002; 35: 964-966.

  15. Lawson JA, Fisher MA, Simmons CA, Farhood A, Jaeschke H. Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in murine models of endotoxin and Fas antibody induced liver injury. Hepatology 1998; 28: 761-767.

  16. Maher JJ, Scott MK, Saito JM, Burton MC. Adenovirus mediated expression of cytokine-induced neutrophil chemoattractant in rat liver induces a neutrophilic hepatitis. Hepatology 1997; 25: 624-630.

  17. Canbay A, Higuchi H, Bronk SF, Taniai M, Sebo TJ, Gores GJ. Fas enhaces fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 2002; 123: 1323-1330.

  18. Canbay A, Guicciardi ME, Higuchi H, Feldstein A, Bronk SF, Rydzewski R, Taniai M, et al. Cathepsin B inactivation attenuates hepatic injury during cholestasis. J Clin Invest 2003; 112: 152-159.

  19. Faouzi S, Burckhardt BE, Hanson JC, Campe CB, Schrum LW, Rippe RA, Maher JJ. Anti- Fas induces hepatic chemokines and promotes inflammation by an NF-kb-independent, caspase 3-dependent-pathway. J Biol Chem 2001; 276: 49077-49082.

  20. Kiener PA, Davis PM, Starling GC , Mehlin C, Klebanoff SJ, Ledbetter JA, Liles WC. Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages. J Exp Med 1997; 185: 1511-1516.

  21. Geske FJ, Monks J, Lehman L, Fadok VA. The role of the macrophage in apoptosis: hunter, gatherer and regulator. Int J Hematol 2002; 76: 16-26.

  22. Chen JJ, Sun Y, Nabel GJ. Regulation of the proinflammatory effects of Fas ligand (CD95L. Science 1998; 282: 1714-1717.

  23. Canbay A, Taimr P, Torok N, Higuchi H, Friedman S, Gores GJ. Apoptotic body engulfment by a human stellate cell line is profibrogenic. Lab Invest 2003; 83: 655-663.

  24. Jaeschke H. Neutrophil- mediated tissue injury in alcoholic hepatits. Alcohol 2002; 7: 23-27.

  25. Hoffmann E, Dittrich- Breiholz O, Holtmann H, Kracht M. Multiple control of interleukin-8 gene expression. J Leukoc Biol 2002; 72: 847-855.

  26. Joshi-Barve S, Barve S, Butt W, Klein J, McClain C. Inhibition of Proteasome Function leads to NF–kb independent IL-8 expression in human Hepatocytes. Hepatology 2003; 38: 1178-1187.

  27. Hill DB, Marzano L, McClain C. Increased plasma IL- 8 concentration in alcoholic hepatitis. Hepatology 1993; 18: 576-580.

  28. Cassiman D, Denef C, Desmet V, Roskams T. Human and rat hepatic stellate cell express neutrophils and neutrophin receptors. Hepatology 2001; 33: 148-158.

  29. Pinzani M, Gentilini P. Biology of hepatic cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis. Semin Liver Dis 1999; 19: 397-410.

  30. Ekataksin W, Kaneda K. Liver macrovascular architecture: an insight into the pathophysiology of portal hypertension. Semin Liver Dis 1999; 19: 359-382.

  31. Saile B, Knittel T, Matthes N, Schott P, Ramadori G. CD95/CD95L- mediated apoptosis of the hepatic stellate cell. A mechanism terminating uncontrolled hepatic stellate cell proliferation during hepatic tissue repair. American Journal of Pathology 151: 1265-1272.

  32. Ratziu V, Lalazar A, Wong L, Dang Q, Collins, Shaulian E, Jensen S, Fridman SL. Zf9, a kruppel- like transcription factor upregulated in vivo during hepatic stellate cell activation. Proceedings of the National Academy of Sciences. USA. 1998: 9500-9505.

  33. Olaso E, Ikeda K, Eng F, Xu L, Wang L, Lin HC, Yancopoulos G, Friedman. DDR2 receptor promotes MMP-2 mediated proliferation and invasion of hepatic stellate cells and during liver injury. Journal of Clinical Investigation 2001; 108: 1369–78.

  34. Viñas O, Bataller R, Sancho-Bru P, Gines P, Berenguer C, Enrich C, Nicolas JM, Ercilla G, Gallart T, Vives J, Arroyo V, Rodes J. Human Hepatic Stellate Cells show features of Antigen–Presenting Cells and Stimulte Lymphocyte Proliferation. Hepatology 2003; 38: 919-929.

  35. Nieto N, Friedman S, Cederbaum A. Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species. Hepatology 2002; 35: 63-73.

  36. Nieto N, Friedman SL, Greenwel P, Cederbaum AI. CYP2EI–mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells. Hepatology 1999; 30: 987-996.

  37. Greenwel P, Geerts A, Ogata I, Solis Herruzo JA, Rojkind M. Liver fibrosis. In: Arias IM, Boyer JL, Fausto N, Jacoby WB, Schachter DA, Shafritz DS, eds. The liver: Biology and pathobiology. 3rd Ed. New York, Raven 1994: 1367-81.

  38. Friedman SL, Molecular mechanism of hepatic fibrosis and principles of therapy. Gastroenterol 1997; 32: 424-30.

  39. Friedrich A. TGF b 1 in liver fibrosis: time to change paradigms? Federation of European Biochemical Societies 2001; 502: 1-3.

  40. Honda H, Ikejima K, Hirose M, Yoshkawa M, Lang T, Enomoto N, Kitamura T, Takei Y, Sato N. Leptin is required for fibrogenic response induced by thioacetamide in the murine liver. Hepatology 2002; 36: 12-21.

  41. Colell A, Garcia-Ruiz C, Roman J, Ballesta A, Fernandez Checa JC. Ganglioside GD3 enhaces apoptosis by supressing the nuclear factor kb- dependent survival pathway. FASEB J 2001; 15: 1068-1070.




2020     |     www.medigraphic.com